Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Bernstein

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Current Medical Research and Opinion|April 7, 2005
A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitisRichard W Yee, Michael Tepedino, Paula Bernstein, et al.
American Journal of Ophthalmology|December 31, 2002
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaRobert S Noecker, Monte S Dirks, Neil T Choplin, et al.
Survey of Ophthalmology|March 16, 2004
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertensionJohn S Cohen, Ronald L Gross, Janet K Cheetham, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 15, 2022
Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS StudiesRobert N Weinreb, Jason Bacharach, Jacob W Brubaker, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Current Medical Research and Opinion|April 7, 2005
A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitisRichard W Yee, Michael Tepedino, Paula Bernstein, et al.
American Journal of Ophthalmology|December 31, 2002
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaRobert S Noecker, Monte S Dirks, Neil T Choplin, et al.
Survey of Ophthalmology|March 16, 2004
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertensionJohn S Cohen, Ronald L Gross, Janet K Cheetham, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 15, 2022
Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS StudiesRobert N Weinreb, Jason Bacharach, Jacob W Brubaker, et al.
Pageof 2